Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Modalis Therapeutics Corporation ( (JP:4883) ) has provided an announcement.
Modalis Therapeutics Corporation announced the terms and conditions for its 16th stock option program, which includes issuing 8,800 share acquisition rights at an exercise price of 9,300 yen per unit. This move is aimed at incentivizing the company’s directors, employees, and subsidiary employees, potentially impacting the company’s market positioning and stakeholder engagement.
More about Modalis Therapeutics Corporation
Modalis Therapeutics Corporation is a company listed on the Tokyo Stock Exchange, focusing on developing therapeutic solutions. Its primary offerings include stock options and share acquisition rights, which are part of its financial and operational strategies.
YTD Price Performance: -24.51%
Average Trading Volume: 2,577,748
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen5.67B
Find detailed analytics on 4883 stock on TipRanks’ Stock Analysis page.